News Canopy links up with major US alcohol distributor Canadian weed titan inks deal with Southern Glazer's to sell its Quatreau CBD drinks across America Jared GnamApril 21, 2021
Industry update Canopy buying Supreme Cannabis for $435M in premium brand grab Analysts question whether consumers will stay loyal to 7Acres under Canopy's stewardship Jared GnamApril 8, 2021
Analysis Canopy shares surge on 2022 profit prediction Despite reporting a $829M Q3 loss, shares are up as the Canadian weed giant predicts US legalization will spur profits Jared GnamFebruary 9, 2021
CBD Martha Stewart and Canopy Growth release CBD dog treats — but are they safe? While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment Ashley KeenanJanuary 31, 2021
The weed wire FDA’s new draft guidelines could speed up CBD drug approvals As industry players await full regulations, the US federal agency continues to slowly open up the CBD market Jared GnamSeptember 29, 2020
The weed wire Canopy launches Martha Stewart CBD line in cluttered US market Canadian weed titan hopes Stewart's celebrity power will catapult it above the 3,000 brands in the US CBD space Jared GnamSeptember 10, 2020
The weed wire Canopy’s recreational cannabis sales continue to decline But the major weed company's stock jumped 7% on strong medical and vaporizer sales Jared GnamAugust 10, 2020
The weed wire NFL superstar Patrick Mahomes partners with Canopy’s BioSteel The reigning Super Bowl MVP will help boost the sports nutrition brand in the US market Jared GnamAugust 5, 2020
The weed wire Canopy launches CBD website in US despite lack of FDA regulations Company now sells CBD sport supplements online despite the US FDA not approving those products Jared GnamJuly 27, 2020
CBD FDA issues cannabis research guidelines as CBD industry still hangs in limbo Vermont cannabis lawyer Timothy Fair calls FDA's two-year delay on CBD regulations 'beyond absurd' Jared GnamJuly 24, 2020